首页 > 最新文献

Clinical and laboratory haematology最新文献

英文 中文
Evaluation of the quality of HLA antibodies in placental blood. 胎盘血HLA抗体质量的评价。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00089.x
Y T Huang, Y S Hsieh, M C Phan, L Wang

Two groups of blood samples, placental blood and female donor blood, were shown to have a frequency of 16.4 and 1.5% of anti-human leucocyte antigen (HLA) antibodies respectively. The specificities and qualities of these antibodies were further characterized by their relative coefficient (r) values and strength indices (SIs). Most had an r value of approximately one, but their SIs varied from 41 to 100%. Among these two groups, nine samples gave very strong and definite results (r = 1 and SI = 100%). Data analysis revealed that the qualities of the two groups were comparable. However, the antibody positive rate was higher in placental blood samples than that in donor blood samples.

胎盘血和女性献血者血两组血液样本的HLA抗体阳性率分别为16.4%和1.5%。通过相对系数(r)值和强度指数(si)进一步表征抗体的特异性和质量。大多数的r值大约为1,但它们的si从41到100%不等。在这两组中,有9个样本给出了非常明确的结果(r = 1, SI = 100%)。数据分析显示,两组的素质是相当的。然而,胎盘血样本的抗体阳性率高于供体血样本。
{"title":"Evaluation of the quality of HLA antibodies in placental blood.","authors":"Y T Huang,&nbsp;Y S Hsieh,&nbsp;M C Phan,&nbsp;L Wang","doi":"10.1046/j.1365-2257.1997.00089.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00089.x","url":null,"abstract":"<p><p>Two groups of blood samples, placental blood and female donor blood, were shown to have a frequency of 16.4 and 1.5% of anti-human leucocyte antigen (HLA) antibodies respectively. The specificities and qualities of these antibodies were further characterized by their relative coefficient (r) values and strength indices (SIs). Most had an r value of approximately one, but their SIs varied from 41 to 100%. Among these two groups, nine samples gave very strong and definite results (r = 1 and SI = 100%). Data analysis revealed that the qualities of the two groups were comparable. However, the antibody positive rate was higher in placental blood samples than that in donor blood samples.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"273-6"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00089.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20386278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pleural effusion secondary to extramedullary haemopoiesis in a patient with idiopathic myelofibrosis responding to pleurodesis and hydroxyurea. 特发性骨髓纤维化患者对胸膜减压和羟基脲反应的继发于髓外造血的胸腔积液。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00080.x
S N Jowitt, D K Burke, H M Leggat, P S Lewis, R J Cryer

A case of idiopathic myelofibrosis presenting with a pleural effusion secondary to extramedullary haemopoeisis is described. Approximately 2 years following the diagnosis of his myeloprolioferative disorder the patient presented with dyspnoea. Physical signs were consistent with a pleural effusion which was confirmed radiologically. Cytology of the effusion fluid demonstrated myeloid precursors, including megakaryocytes. The effusion required repeated draining and a pleurodesis was undertaken in an attempt to prevent reaccumulation of the fluid. The procedure was successful and follow up over a period of 5 months demonstrated no recurrence of the pleural effusion on that side of the chest. An effusion later occurred on the other side but was managed conservatively by drainage. Hydroxyurea was introduced at that stage, but shortly afterwards the patient died from an unrelated cause. We review the literature on this uncommon complication of myelofibrosis and discuss the options available to treat the disorder.

特发性骨髓纤维化的情况下,表现为继发髓外造血的胸腔积液被描述。在诊断出骨髓增生性疾病大约2年后,患者出现呼吸困难。体征符合胸膜积液,放射学证实。渗出液细胞学显示髓系前体,包括巨核细胞。积液需要反复引流,并进行胸膜清扫,以防止积液重新积聚。手术很成功,5个月的随访表明,该侧胸腔没有再发生胸腔积液。后来另一侧发生积液,但经引流保守处理。在这个阶段引入了羟基脲,但不久之后患者死于一个无关的原因。我们回顾了这种罕见的骨髓纤维化并发症的文献,并讨论了治疗这种疾病的选择。
{"title":"Pleural effusion secondary to extramedullary haemopoiesis in a patient with idiopathic myelofibrosis responding to pleurodesis and hydroxyurea.","authors":"S N Jowitt,&nbsp;D K Burke,&nbsp;H M Leggat,&nbsp;P S Lewis,&nbsp;R J Cryer","doi":"10.1046/j.1365-2257.1997.00080.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00080.x","url":null,"abstract":"<p><p>A case of idiopathic myelofibrosis presenting with a pleural effusion secondary to extramedullary haemopoeisis is described. Approximately 2 years following the diagnosis of his myeloprolioferative disorder the patient presented with dyspnoea. Physical signs were consistent with a pleural effusion which was confirmed radiologically. Cytology of the effusion fluid demonstrated myeloid precursors, including megakaryocytes. The effusion required repeated draining and a pleurodesis was undertaken in an attempt to prevent reaccumulation of the fluid. The procedure was successful and follow up over a period of 5 months demonstrated no recurrence of the pleural effusion on that side of the chest. An effusion later occurred on the other side but was managed conservatively by drainage. Hydroxyurea was introduced at that stage, but shortly afterwards the patient died from an unrelated cause. We review the literature on this uncommon complication of myelofibrosis and discuss the options available to treat the disorder.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"283-5"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00080.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20386281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
An improved method for thick film preparation using saponin as a lysing agent. 以皂素为裂解剂制备厚膜的改进方法。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00094.x
R M Gleeson

Thick film examination for malaria is often hampered by the presence of cellular debris obscuring parasites. This is a major problem for diagnostic laboratories that do not have a high exposure to material identification. Films that are relatively free of cellular debris, allowing easier identification of parasites are an obvious advantage. Saponin has been used by researchers to liberate malarial parasites for harvesting from infected erythrocytes. It has also been used for thick film preparations for diagnosis, but has not gained widespread acceptance, possibly due to the persistence of cellular debris inherent in the technique. In the present study the saponin method for thick film examination has been modified by the inclusion of a centrifugation step to remove cellular debris. Thick films were run in parallel with films made using the standard Fields stain technique and the original saponin. Results indicate that the modified saponin technique provides superior preparations free of cellular debris.

疟疾的厚膜检查常常因存在掩盖寄生虫的细胞碎片而受到阻碍。这是诊断实验室的一个主要问题,没有高度接触的材料鉴定。膜相对没有细胞碎片,使寄生虫更容易识别,这是一个明显的优势。研究人员已经使用皂素来释放疟疾寄生虫,以便从受感染的红细胞中收获。它也被用于厚膜诊断准备,但尚未获得广泛接受,可能是由于该技术固有的细胞碎片的持久性。在本研究中,厚膜检查的皂素方法已被修改,包括离心步骤,以去除细胞碎片。厚膜与使用标准菲尔兹染色技术和原始皂素制作的膜平行运行。结果表明,该技术可提供无细胞碎片的优良制剂。
{"title":"An improved method for thick film preparation using saponin as a lysing agent.","authors":"R M Gleeson","doi":"10.1046/j.1365-2257.1997.00094.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00094.x","url":null,"abstract":"<p><p>Thick film examination for malaria is often hampered by the presence of cellular debris obscuring parasites. This is a major problem for diagnostic laboratories that do not have a high exposure to material identification. Films that are relatively free of cellular debris, allowing easier identification of parasites are an obvious advantage. Saponin has been used by researchers to liberate malarial parasites for harvesting from infected erythrocytes. It has also been used for thick film preparations for diagnosis, but has not gained widespread acceptance, possibly due to the persistence of cellular debris inherent in the technique. In the present study the saponin method for thick film examination has been modified by the inclusion of a centrifugation step to remove cellular debris. Thick films were run in parallel with films made using the standard Fields stain technique and the original saponin. Results indicate that the modified saponin technique provides superior preparations free of cellular debris.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"249-51"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00094.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20387026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant. 异体外周血祖细胞移植治疗经摇头丸诱导的严重再生障碍性贫血合并侵袭性肺粘膜真菌病。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00086.x
A D Clark, N Butt

Very severe aplastic anaemia (vSAA) is rare. We report a case of Ecstasy-induced very severe aplastic anaemia which did not respond to immunosuppressive therapy, developing invasive pulmonary mucormycosis. The patient underwent an HLA-identical sibling peripheral blood progenitor cell transplant (PBPCT) with rapid neutrophil engraftment. During engraftment he developed life-threatening adult respiratory distress syndrome (ARDS). This case serves to illustrate a novel aetiology of vSAA where the infective complications responded to prompt haematopoietic engraftment.

非常严重再生障碍性贫血(vSAA)是罕见的。我们报告一例由摇头丸引起的非常严重的再生障碍性贫血,对免疫抑制治疗没有反应,发展为侵袭性肺毛霉菌病。患者接受了hla相同的同胞外周血祖细胞移植(PBPCT)和快速中性粒细胞植入。在移植过程中,他出现了危及生命的成人呼吸窘迫综合征(ARDS)。这个病例说明了一种新的vSAA病因学,其中感染并发症对及时的造血移植有反应。
{"title":"Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant.","authors":"A D Clark,&nbsp;N Butt","doi":"10.1046/j.1365-2257.1997.00086.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00086.x","url":null,"abstract":"<p><p>Very severe aplastic anaemia (vSAA) is rare. We report a case of Ecstasy-induced very severe aplastic anaemia which did not respond to immunosuppressive therapy, developing invasive pulmonary mucormycosis. The patient underwent an HLA-identical sibling peripheral blood progenitor cell transplant (PBPCT) with rapid neutrophil engraftment. During engraftment he developed life-threatening adult respiratory distress syndrome (ARDS). This case serves to illustrate a novel aetiology of vSAA where the infective complications responded to prompt haematopoietic engraftment.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"279-81"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00086.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20386280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Evaluation of a nurse specialist anticoagulant service. 专科护士抗凝服务的评价。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00082.x
F C Taylor, E Gaminara, H Cohen, M Ramsay, D Miller

Safe levels of anticoagulation are normally considered to be achieved if patients are maintained within their therapeutic international normalized ratio (INR) range for 70% or more time, but evidence in the United Kingdom suggests that this is often not attained. Recently, alternative models in the management of out-patient anticoagulation have been investigated with favourable results. We report on a study which compared a consultant anticoagulant service (CAS) with a nurse specialist service (NSAS). A sequential design was used with data collected on the consultant run service (CAS), followed by similar data on a NSAS over two 6 month periods. Two patient groups were recruited: those newly referred (group A) and those on long-term treatment (group B). Outcomes were the proportion of time patients spent within INR range, documentation of relevant clinical details, number of drugs taken which may adversely interact with and/or inhibit haemostatic function and patient knowledge. The results indicate that the NSAS was as good as the CAS in maintaining therapeutic control and better at documenting relevant clinical details in reducing the number of drugs taken which may adversely interact with and/or inhibit haemostatic function and in improving some aspects of patient knowledge.

如果患者在治疗性国际标准化比率(INR)范围内维持70%或更长时间,通常被认为达到了安全抗凝水平,但英国的证据表明,这通常无法达到。最近,在门诊抗凝治疗管理的替代模式已进行了调查,并取得了良好的结果。我们报告了一项比较咨询抗凝服务(CAS)和护士专科服务(NSAS)的研究。在咨询师运行服务(CAS)上收集的数据采用顺序设计,随后在两个6个月期间在NSAS上收集类似数据。招募了两组患者:新转诊的患者(A组)和长期治疗的患者(B组)。结果是患者在INR范围内的时间比例、相关临床细节的记录、可能与止血功能产生不良相互作用和/或抑制止血功能的药物的数量以及患者的知识。结果表明,NSAS在维持治疗控制方面与CAS一样好,在记录相关临床细节方面更好,减少了可能与止血功能产生不良相互作用和/或抑制止血功能的药物的服用数量,并提高了患者知识的某些方面。
{"title":"Evaluation of a nurse specialist anticoagulant service.","authors":"F C Taylor,&nbsp;E Gaminara,&nbsp;H Cohen,&nbsp;M Ramsay,&nbsp;D Miller","doi":"10.1046/j.1365-2257.1997.00082.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00082.x","url":null,"abstract":"<p><p>Safe levels of anticoagulation are normally considered to be achieved if patients are maintained within their therapeutic international normalized ratio (INR) range for 70% or more time, but evidence in the United Kingdom suggests that this is often not attained. Recently, alternative models in the management of out-patient anticoagulation have been investigated with favourable results. We report on a study which compared a consultant anticoagulant service (CAS) with a nurse specialist service (NSAS). A sequential design was used with data collected on the consultant run service (CAS), followed by similar data on a NSAS over two 6 month periods. Two patient groups were recruited: those newly referred (group A) and those on long-term treatment (group B). Outcomes were the proportion of time patients spent within INR range, documentation of relevant clinical details, number of drugs taken which may adversely interact with and/or inhibit haemostatic function and patient knowledge. The results indicate that the NSAS was as good as the CAS in maintaining therapeutic control and better at documenting relevant clinical details in reducing the number of drugs taken which may adversely interact with and/or inhibit haemostatic function and in improving some aspects of patient knowledge.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"267-72"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00082.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20387029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Parvovirus-induced pancytopenia in a child with acquired haemolytic anaemia. 获得性溶血性贫血儿童的细小病毒诱导全血细胞减少症。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00071.x
B Myers, G Dolan

A 14-year-old boy, with acquired haemolytic anaemia secondary to paravalvular leak from a prosthetic aortic valve, presented with severe pancytopenia. Subsequent investigation showed serological evidence of recent parvovirus B19 infection. The patient required transfusion and subsequently improved rapidly, with maintenance of pre-infective haemoglobin levels. To our knowledge this is the first reported case in which infection with parvovirus has caused pancytopenia in an acquired chronic mechanical haemolytic anaemia.

一个14岁的男孩,获得性溶血性贫血继发于假体主动脉瓣瓣旁泄漏,表现为严重的全血细胞减少症。随后的调查显示最近有细小病毒B19感染的血清学证据。患者需要输血,随后迅速好转,维持感染前血红蛋白水平。据我们所知,这是首例报道的感染细小病毒导致获得性慢性机械性溶血性贫血全血细胞减少的病例。
{"title":"Parvovirus-induced pancytopenia in a child with acquired haemolytic anaemia.","authors":"B Myers,&nbsp;G Dolan","doi":"10.1046/j.1365-2257.1997.00071.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00071.x","url":null,"abstract":"<p><p>A 14-year-old boy, with acquired haemolytic anaemia secondary to paravalvular leak from a prosthetic aortic valve, presented with severe pancytopenia. Subsequent investigation showed serological evidence of recent parvovirus B19 infection. The patient required transfusion and subsequently improved rapidly, with maintenance of pre-infective haemoglobin levels. To our knowledge this is the first reported case in which infection with parvovirus has caused pancytopenia in an acquired chronic mechanical haemolytic anaemia.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"277-8"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00071.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20386279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Rapid diagnosis of chronic myeloid leukaemia by linking PCR to capillary gel electrophoresis. PCR与毛细管凝胶电泳联用快速诊断慢性髓性白血病。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00079.x
P P Kearney, A Aumatell

The move to the use of molecular diagnostics in medicine has gathered momentum in the last few years and new methodologies are being sought to reduce the labour component and hence the cost of these molecular diagnostics. A method is described which links PCR to capillary electrophoresis and this allows both a rapid and quantitative diagnosis. In the example provided, the diagnosis of chronic myeloid leukaemia, the method describes improvements in cost per test, greater sensitivity over traditional methods and an estimate of the level of product. The latter points are important in those disorders for which bone marrow transplantation is used as a curative regime in providing earlier detection of relapse.

在过去几年中,在医学中使用分子诊断的势头日益增强,人们正在寻求新的方法,以减少这些分子诊断的劳动力组成部分,从而降低成本。描述了一种方法,将PCR与毛细管电泳联系起来,这使得快速定量诊断成为可能。在所提供的慢性髓性白血病诊断示例中,该方法描述了每次检测成本的改进、比传统方法更大的灵敏度以及对产品水平的估计。后一点对于那些骨髓移植被用作早期发现复发的治疗方案的疾病是重要的。
{"title":"Rapid diagnosis of chronic myeloid leukaemia by linking PCR to capillary gel electrophoresis.","authors":"P P Kearney,&nbsp;A Aumatell","doi":"10.1046/j.1365-2257.1997.00079.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00079.x","url":null,"abstract":"<p><p>The move to the use of molecular diagnostics in medicine has gathered momentum in the last few years and new methodologies are being sought to reduce the labour component and hence the cost of these molecular diagnostics. A method is described which links PCR to capillary electrophoresis and this allows both a rapid and quantitative diagnosis. In the example provided, the diagnosis of chronic myeloid leukaemia, the method describes improvements in cost per test, greater sensitivity over traditional methods and an estimate of the level of product. The latter points are important in those disorders for which bone marrow transplantation is used as a curative regime in providing earlier detection of relapse.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"261-6"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00079.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20387028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Introduction of nurse specialists into the anticoagulant clinic: issues to consider. 在抗凝门诊引入专科护士:需要考虑的问题。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00088.x
E Gaminara, F C Taylor, D Miller, A Gray, M Ramsay, H Cohen
{"title":"Introduction of nurse specialists into the anticoagulant clinic: issues to consider.","authors":"E Gaminara,&nbsp;F C Taylor,&nbsp;D Miller,&nbsp;A Gray,&nbsp;M Ramsay,&nbsp;H Cohen","doi":"10.1046/j.1365-2257.1997.00088.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00088.x","url":null,"abstract":"","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"287-8"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00088.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20386282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluation of the Abbott Cell Dyn 4000 automated fluorescent reticulocyte measurements: comparison with manual, FACScan and Sysmex R1000 methods. 评估雅培细胞Dyn 4000自动荧光网织红细胞测量:与手动,FACScan和Sysmex R1000方法的比较。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00078.x
G d'Onofrio, Y R Kim, S Schulze, T Lorentz, K Dörner, W Goossens, G Zini, M Tommasi, R Kendall, C S Scott

The Abbott Cell Dyn 4000 (CD4000) is the first haematology analyser in which fully-automated reticulocyte measurements can be routinely determined by fluorescence as part of the full blood count. This communication reports the first evaluation of this method which was undertaken by three independent reference laboratories in Belgium, Germany and Italy. A total of 695 different samples was entered into the study which was designed to compare CD4000 reticulocyte information (enumeration and qualitative maturational data) with results determined in parallel with the existing manual (supravital staining) reference procedure, and two semi-automated fluorescent assays (Becton Dickinson FACScan and Sysmex R1000 instruments). These studies revealed good agreement between the CD4000 and the manual procedure, with no inter-method bias. Comparison of CD4000 and FACScan reticulocyte measurements, however, indicated a distinct tendency for the FACScan to give higher reticulocyte estimates than the CD4000. Finally, the comparison of the CD4000 with the Sysmex R1000 showed excellent agreement in the range 0-6% reticulocytes, although there was some inter-method bias in the higher range (> 15%). Analysis of agreement levels between the methods using specific 'clinical decision points' confirmed the tendency for overestimation by the FACScan, in that 58% of the samples with a reticulocytopenia of < 0.5% as defined by the CD4000 gave FACScan results within the normal range (0.5-1.8%). In contrast, there was absolute agreement between the CD4000 and the Sysmex R1000 for all reticulocytopenias. Comparison (195 samples) of instrument fluorescent reticulocyte maturation profiles demonstrated an exponential relationship (r = 0.78) between CD4000 IRF and R1000 HFR (highly fluorescent reticulocyte fraction) values. The suggestion that the CD4000 IRF values includes some of the MFR as well the HFR reticulocyte fraction was confirmed as the correlation between the CD4000 IRF and the Sysmex R1000 MFR plus HFR percentages was linear (r = 0.82). This study confirms a high performance level for the CD4000 automated fluorescent reticulocyte method.

雅培细胞Dyn 4000 (CD4000)是第一个血液学分析仪,其中全自动网织红细胞测量可以通过荧光常规确定作为全血细胞计数的一部分。本通讯报告了比利时、德国和意大利三个独立参考实验室对该方法进行的第一次评价。共有695个不同的样本被纳入研究,目的是将CD4000网网红细胞信息(计数和定性成熟数据)与现有的手工(上活体染色)参考程序和两种半自动荧光测定(Becton Dickinson FACScan和Sysmex R1000仪器)平行测定的结果进行比较。这些研究显示CD4000和人工程序之间有很好的一致性,没有方法间的偏差。然而,比较CD4000和FACScan的网织红细胞测量结果表明,FACScan给出的网织红细胞估计值明显高于CD4000。最后,CD4000与Sysmex R1000的比较在0-6%的网织红细胞范围内显示出极好的一致性,尽管在较高的范围内存在一些方法间偏差(> 15%)。使用特定“临床决策点”的方法之间的一致性水平分析证实了FACScan高估的趋势,在CD4000定义的网织红细胞减少症< 0.5%的样本中,58%的FACScan结果在正常范围内(0.5-1.8%)。相比之下,CD4000和Sysmex R1000对所有网状红细胞减少症的治疗结果完全一致。比较195个样本的仪器荧光网织红细胞成熟谱,CD4000 IRF和R1000高荧光网织红细胞分数(HFR)值之间呈指数关系(r = 0.78)。CD4000 IRF值包括一些MFR以及HFR网状细胞分数的建议被证实为CD4000 IRF与Sysmex R1000 MFR加HFR百分比之间的相关性是线性的(r = 0.82)。本研究证实了CD4000自动荧光网织红细胞法的高性能水平。
{"title":"Evaluation of the Abbott Cell Dyn 4000 automated fluorescent reticulocyte measurements: comparison with manual, FACScan and Sysmex R1000 methods.","authors":"G d'Onofrio,&nbsp;Y R Kim,&nbsp;S Schulze,&nbsp;T Lorentz,&nbsp;K Dörner,&nbsp;W Goossens,&nbsp;G Zini,&nbsp;M Tommasi,&nbsp;R Kendall,&nbsp;C S Scott","doi":"10.1046/j.1365-2257.1997.00078.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00078.x","url":null,"abstract":"<p><p>The Abbott Cell Dyn 4000 (CD4000) is the first haematology analyser in which fully-automated reticulocyte measurements can be routinely determined by fluorescence as part of the full blood count. This communication reports the first evaluation of this method which was undertaken by three independent reference laboratories in Belgium, Germany and Italy. A total of 695 different samples was entered into the study which was designed to compare CD4000 reticulocyte information (enumeration and qualitative maturational data) with results determined in parallel with the existing manual (supravital staining) reference procedure, and two semi-automated fluorescent assays (Becton Dickinson FACScan and Sysmex R1000 instruments). These studies revealed good agreement between the CD4000 and the manual procedure, with no inter-method bias. Comparison of CD4000 and FACScan reticulocyte measurements, however, indicated a distinct tendency for the FACScan to give higher reticulocyte estimates than the CD4000. Finally, the comparison of the CD4000 with the Sysmex R1000 showed excellent agreement in the range 0-6% reticulocytes, although there was some inter-method bias in the higher range (> 15%). Analysis of agreement levels between the methods using specific 'clinical decision points' confirmed the tendency for overestimation by the FACScan, in that 58% of the samples with a reticulocytopenia of < 0.5% as defined by the CD4000 gave FACScan results within the normal range (0.5-1.8%). In contrast, there was absolute agreement between the CD4000 and the Sysmex R1000 for all reticulocytopenias. Comparison (195 samples) of instrument fluorescent reticulocyte maturation profiles demonstrated an exponential relationship (r = 0.78) between CD4000 IRF and R1000 HFR (highly fluorescent reticulocyte fraction) values. The suggestion that the CD4000 IRF values includes some of the MFR as well the HFR reticulocyte fraction was confirmed as the correlation between the CD4000 IRF and the Sysmex R1000 MFR plus HFR percentages was linear (r = 0.82). This study confirms a high performance level for the CD4000 automated fluorescent reticulocyte method.</p>","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"253-60"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00078.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20387027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. CD4+ T lymphocyte Working Party. Members of the General Haematology Task Force of BCSH. 免疫抑制个体CD4+ T淋巴细胞计数指南。CD4+ T淋巴细胞工作组。bsh普通血液学工作组成员。
Pub Date : 1997-12-01 DOI: 10.1046/j.1365-2257.1997.00091.x
{"title":"Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. CD4+ T lymphocyte Working Party. Members of the General Haematology Task Force of BCSH.","authors":"","doi":"10.1046/j.1365-2257.1997.00091.x","DOIUrl":"https://doi.org/10.1046/j.1365-2257.1997.00091.x","url":null,"abstract":"","PeriodicalId":10285,"journal":{"name":"Clinical and laboratory haematology","volume":"19 4","pages":"231-41"},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1365-2257.1997.00091.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20385721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 40
期刊
Clinical and laboratory haematology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1